← Evidence map

ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2026

From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate.

Björn Capsius et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42762279